G. P. Segoloni

611 total citations
37 papers, 463 citations indexed

About

G. P. Segoloni is a scholar working on Transplantation, Nephrology and Epidemiology. According to data from OpenAlex, G. P. Segoloni has authored 37 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Transplantation, 8 papers in Nephrology and 7 papers in Epidemiology. Recurrent topics in G. P. Segoloni's work include Renal Transplantation Outcomes and Treatments (10 papers), Cytomegalovirus and herpesvirus research (7 papers) and Dialysis and Renal Disease Management (5 papers). G. P. Segoloni is often cited by papers focused on Renal Transplantation Outcomes and Treatments (10 papers), Cytomegalovirus and herpesvirus research (7 papers) and Dialysis and Renal Disease Management (5 papers). G. P. Segoloni collaborates with scholars based in Italy, United States and Canada. G. P. Segoloni's co-authors include Giovanni Camussi, Ciro Tetta, Fabrizio Fop, Luigi Biancone, Cristina Grange, Vincenzo Cantaluppi, Maria Chiara Deregibus, Loriana Vitillo, Andrea Ranghino and Melissa Rotunno and has published in prestigious journals such as The Journal of Immunology, Transplantation and Nephrology Dialysis Transplantation.

In The Last Decade

G. P. Segoloni

34 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. P. Segoloni Italy 11 152 139 80 74 73 37 463
Saowanee Yenrudi Thailand 9 138 0.9× 128 0.9× 81 1.0× 84 1.1× 69 0.9× 21 524
Jennifer M. Bird United Kingdom 14 55 0.4× 288 2.1× 13 0.2× 62 0.8× 19 0.3× 23 918
Li Xie China 13 59 0.4× 152 1.1× 77 1.0× 126 1.7× 49 0.7× 30 630
Virginia Bosó Spain 16 23 0.2× 118 0.8× 20 0.3× 118 1.6× 47 0.6× 40 628
A. D. Hibberd Australia 13 51 0.3× 35 0.3× 43 0.5× 149 2.0× 8 0.1× 39 405
Javed Iqbal Kazi Pakistan 15 397 2.6× 117 0.8× 7 0.1× 118 1.6× 18 0.2× 47 610
Reiad Najjar United States 15 168 1.1× 35 0.3× 38 0.5× 316 4.3× 29 0.4× 26 742
Mahfooz Farooqui Saudi Arabia 9 57 0.4× 63 0.5× 20 0.3× 24 0.3× 15 0.2× 25 332
Supreet Sethi United States 14 149 1.0× 26 0.2× 36 0.5× 255 3.4× 29 0.4× 24 559
Sam Kant United States 13 85 0.6× 34 0.2× 15 0.2× 84 1.1× 98 1.3× 48 422

Countries citing papers authored by G. P. Segoloni

Since Specialization
Citations

This map shows the geographic impact of G. P. Segoloni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. P. Segoloni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. P. Segoloni more than expected).

Fields of papers citing papers by G. P. Segoloni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. P. Segoloni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. P. Segoloni. The network helps show where G. P. Segoloni may publish in the future.

Co-authorship network of co-authors of G. P. Segoloni

This figure shows the co-authorship network connecting the top 25 collaborators of G. P. Segoloni. A scholar is included among the top collaborators of G. P. Segoloni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. P. Segoloni. G. P. Segoloni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Triolo, G, et al.. (2015). Reduction of the Risk of Acute Tubular Necrosis in Ciclosporin-Treated Patients. Contributions to nephrology. 51. 143–146.
2.
Rittà, Massimo, Cristina Costa, Francesca Sidoti, et al.. (2013). Evaluation of Epstein-Barr Virus–Specific Immunologic Response in Solid Organ Transplant Recipients With an Enzyme-Linked ImmunoSpot Assay. Transplantation Proceedings. 45(7). 2754–2757. 10 indexed citations
3.
Ferro, Mariza, M. Messina, Fabrizio Fop, et al.. (2009). Assessment of cardiovascular risk in waiting‐listed renal transplant patients: a single center experience in 558 cases. Clinical Transplantation. 23(5). 653–659. 11 indexed citations
4.
Costa, Cristina, F Giacchino, Chiara Merlino, et al.. (2006). Non-organ-specific autoantibodies and CMV infection in renal transplant recipients with or without rejection.. Nephrology Dialysis Transplantation. 278–279. 1 indexed citations
5.
Bergallo, Massimiliano, Cristina Costa, Sonia Tarallo, et al.. (2006). Development of a quantitative-competitive PCR for quantification of human cytomegalovirus load and comparison with antigenaemia, viraemia and pp67 RNA detection by nucleic acid sequence-based amplification.. PubMed. 48(2). 119–27. 7 indexed citations
6.
Burdese, Manuel, et al.. (2005). 'Primary' nephrosclerosis in a type 1 diabetic patient. Nephrology Dialysis Transplantation. 20(4). 817–819. 1 indexed citations
7.
Mezza, Elisabetta, Valentina Consiglio, Manuel Burdese, et al.. (2005). CKD Patients and Erythropoietin: Do We Need Evidence-Based Informed Consent?. The International Journal of Artificial Organs. 28(6). 591–599.
8.
Jeantet, A, Giorgina Barbara Piccoli, M. Messina, et al.. (2004). Preparation of candidates for renal transplantation: cost analysis. Transplantation Proceedings. 36(3). 455–456. 4 indexed citations
9.
Piccoli, Giorgina Barbara, Elisabetta Mezza, Monica Bravin, et al.. (2004). Tailored dialysis start may allow persistence of residual renal function after graft failure: A case report. Transplantation Proceedings. 36(9). 2607–2609. 6 indexed citations
10.
Segoloni, G. P., et al.. (2004). A CALCINEURIN-INHIBITOR FREE PROTOCOL FOR RENAL TRANSPLANTATION IN AN “OLD FOR OLD” ALLOCATION: TWO YEAR RESULTS. Transplantation. 78. 272–272. 1 indexed citations
11.
Cavallo, Rossana, Chiara Merlino, Massimiliano Bergallo, et al.. (2003). B19 virus infection in renal transplant recipients. Journal of Clinical Virology. 26(3). 361–368. 63 indexed citations
12.
Fop, Fabrizio, et al.. (2001). The impact of antilymphocyte therapy on sensitized patients in renal transplantation. Transplantation Proceedings. 33(1-2). 1090–1090.
13.
Segoloni, G. P., M Messina, Daniela Damiani, et al.. (1998). Survival probabilities for renal transplant recipients and dialytic patients: a single center prospective study. Transplantation Proceedings. 30(5). 1739–1741. 13 indexed citations
14.
Biancone, Luigi, D Donati, G. P. Segoloni, et al.. (1998). Study of lymphocyte costimulatory molecules in renal transplantation. Transplantation Proceedings. 30(5). 2384–2386. 4 indexed citations
15.
Segoloni, G. P., G Triolo, Maurizio Cassader, et al.. (1993). Dyslipidemia in renal transplantation: a 3-year follow-up.. PubMed. 25(3). 2178–9. 10 indexed citations
16.
Triolo, G, M. Baldi, M Messina, et al.. (1992). Antibodies to Hepatitis C Virus in Kidney Transplantation. ˜The œNephron journals/Nephron journals. 61(3). 276–277. 10 indexed citations
17.
Lupo, Antonio, Giovanni Cancarini, Luigi Catizone, et al.. (1992). Comparison of survival in CAPD and hemodialysis: a multicenter study.. PubMed. 8. 136–40. 14 indexed citations
18.
Segoloni, G. P., et al.. (1990). Immunoglobulin abnormalities in transplant patients: a method for typing monoclonal immunoglobulins.. PubMed. 22(4). 1867–8. 2 indexed citations
19.
Triolo, G, et al.. (1981). Changes in Serum Lipids with Prolonged CAPD. Peritoneal Dialysis International. 2(4). 192–192. 2 indexed citations
20.
Camussi, Giovanni, et al.. (1977). In vivo fixation of immune complexes on polymorphonuclear cells and release of neutrophil cationic proteins in systemic lupus erythematosus (SLE).. PubMed. 14. 478–85. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026